Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

German (DAX) Materials Sector Analysis

UpdatedDec 30, 2025
DataAggregated Company Financials
Companies32
  • 7D0.9%
  • 3M4.6%
  • 1Y18.9%
  • YTD18.5%

Over the last 7 days, the Materials industry has remained flat. The past year has been better, since the industry has gained 19% in that time. Looking forward, earnings are forecast to grow by 30% annually.

Sector Valuation and Performance

Has the German Materials Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 30 Dec 2025€134.3b€202.4b€1.6b22.1x82.3x0.7x
Thu, 27 Nov 2025€133.3b€202.7b€10.8m20.9x12347.6x0.7x
Sat, 25 Oct 2025€132.3b€204.7b€438.5m22.6x301.7x0.6x
Mon, 22 Sep 2025€130.6b€204.7b€438.5m20.9x297.8x0.6x
Wed, 20 Aug 2025€137.6b€207.3b€239.2m21.5x575.4x0.7x
Fri, 18 Jul 2025€134.7b€209.4b€2.5b20.8x54.7x0.6x
Sun, 15 Jun 2025€130.2b€209.4b€2.2b20.1x60.3x0.6x
Tue, 13 May 2025€135.0b€207.8b€2.0b19.4x66.4x0.6x
Thu, 10 Apr 2025€118.7b€207.3b€3.0b15.2x39.9x0.6x
Sat, 08 Mar 2025€141.1b€207.3b€2.5b19.4x56.3x0.7x
Mon, 03 Feb 2025€122.0b€206.9b€1.4b16.2x89.6x0.6x
Wed, 01 Jan 2025€113.4b€206.9b€1.4b15x83.2x0.5x
Fri, 29 Nov 2024€114.1b€206.8b€1.3b15.2x86.3x0.6x
Sun, 27 Oct 2024€125.0b€213.7b-€469,232,630.3713.6x-266.4x0.6x
Tue, 24 Sep 2024€116.5b€206.9b-€490,500,019.4414.4x-237.5x0.6x
Thu, 22 Aug 2024€112.3b€207.0b-€467,338,114.9814.3x-240.4x0.5x
Sat, 20 Jul 2024€117.7b€209.2b-€534,620,472.1613.4x-220.1x0.6x
Mon, 17 Jun 2024€114.4b€209.2b-€532,208,462.7513.9x-214.9x0.5x
Wed, 15 May 2024€121.5b€210.2b-€679,246,808.9013.9x-178.8x0.6x
Fri, 12 Apr 2024€123.2b€214.7b-€26,650,427.1412.2x-4624.3x0.6x
Sun, 10 Mar 2024€116.7b€216.9b€1.4b10.5x85x0.5x
Tue, 06 Feb 2024€111.0b€222.9b-€2,535,232,795.5411x-43.8x0.5x
Thu, 04 Jan 2024€116.4b€223.8b-€2,614,259,274.0012.4x-44.5x0.5x
Sat, 02 Dec 2023€115.6b€225.0b-€2,486,777,288.0010.8x-46.5x0.5x
Mon, 30 Oct 2023€106.2b€234.6b€2.1b11x50.6x0.5x
Wed, 27 Sep 2023€109.0b€236.3b€2.4b10x45.9x0.5x
Fri, 25 Aug 2023€113.3b€236.3b€2.4b10.6x47.7x0.5x
Sun, 23 Jul 2023€117.8b€247.2b€5.8b10.9x20.2x0.5x
Tue, 20 Jun 2023€111.6b€247.2b€5.8b13x19.2x0.5x
Thu, 18 May 2023€116.6b€247.8b€6.7b10.6x17.5x0.5x
Sat, 15 Apr 2023€120.9b€252.8b€7.7b10.2x15.8x0.5x
Mon, 13 Mar 2023€118.3b€253.3b€7.8b10.5x15.2x0.5x
Wed, 08 Feb 2023€126.0b€252.0b€15.2b9.3x8.3x0.5x
Fri, 06 Jan 2023€119.3b€252.3b€15.5b9x7.7x0.5x
Price to Earnings Ratio

7.7x


Total Market Cap: €119.3bTotal Earnings: €15.5bTotal Revenue: €252.3bTotal Market Cap vs Earnings and Revenue0%0%0%
German Materials Sector Price to Earnings3Y Average 50.9x20242025
Current Industry PE
  • Investors are optimistic on the German Materials industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 82.3x which is higher than its 3-year average PE of 50.9x.
  • The industry is trading close to its 3-year average PS ratio of 0.55x.
Past Earnings Growth
  • The earnings for companies in the Materials industry have declined 53% per year over the last three years,
  • Revenues have also declined 7.1% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the German Materials sector?

DE Market0.32%
Materials0.94%
Paper and Forestry Products2.79%
Packaging2.26%
Metals and Mining1.39%
Basic Materials0.93%
Chemicals0.87%
Industry PE
  • Investors are most optimistic about the Paper and Forestry Products industry which is trading above its 3-year average PE ratio of 37.0x.
    • Analysts are expecting annual earnings growth of 53.9%, which is higher than its past year's earnings decline of 55.9% per year.
Forecasted Growth
  • Analysts are most optimistic on the Paper and Forestry Products industry, expecting annual earnings growth of 54% over the next 5 years.
  • This is better than its past earnings decline of 56% per year.
  • In contrast, the Basic Materials industry is expected to see its earnings grow by 11% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BAS BASF€44.431.8%
+€700.0m		4.6%PE127.4x
HEI Heidelberg Materials€223.000.6%
+€229.3m		86.9%PE21.1x
NDA Aurubis€124.202.3%
+€122.2m		61.9%PE10.1x
EVK Evonik Industries€13.361.9%
+€116.5m		-20.1%PE66.2x
ACT AlzChem Group€155.006.7%
+€99.0m		171.9%PE25.3x

Latest News

HEI
€223.00
Heidelberg Materials
7D
0.6%
1Y
86.9%

Heidelberg Materials AG's (ETR:HEI) Shareholders Might Be Looking For Exit

Dec 29
Heidelberg Materials AG's (ETR:HEI) Shareholders Might Be Looking For Exit
BAS
€44.43
BASF
7D
1.8%
1Y
4.6%

BAS: Coatings Sale Will Leave Limited Upside As Cyclical Headwinds Persist

Analysts have modestly raised their price target on BASF to EUR 52.00, citing a more favorable margin outlook supported by the sale price achieved for the coatings business, which came in ahead of expectations. Analyst Commentary While the latest coverage restart with a Buy rating and a EUR 52 price target underscores improved confidence in BASF's margin trajectory, sentiment across the broader analyst community remains mixed.
EVK
€13.36
Evonik Industries
7D
1.9%
1Y
-20.1%

EVK: Cost Discipline And Specialty Focus Will Support Medium-Term Upside Potential

Evonik Industries’ latest narrative update reflects a lowered analyst price target to EUR 20.40 from EUR 25.00, as analysts factor in softer revenue growth, slightly compressed profit margins, and a reduced future P/E multiple amid a more cautious sector stance. Analyst Commentary Recent Street research on Evonik Industries reflects a more nuanced view, with a mix of cautious sector positioning and selective optimism on the company’s ability to execute amid a tougher macro backdrop.
SY1
€68.88
Symrise
7D
0.7%
1Y
-32.9%

SY1: Margin Expansion And Diversified Demand Will Support Future Upside

Our Symrise fair value estimate has been trimmed by about EUR 1.50 per share, reflecting analysts' slightly lower long term revenue growth expectations and modestly reduced earnings multiples following a series of recent price target cuts. Analyst Commentary Recent price target revisions have been modestly negative on balance, but the tone of Street research remains mixed, with both upside and downside scenarios framed largely around execution on growth initiatives and margin delivery.
BNN
€2.52
BRAIN Biotech
7D
-3.1%
1Y
-29.0%

Market Cool On BRAIN Biotech AG's (ETR:BNN) Revenues Pushing Shares 28% Lower

Dec 22
Market Cool On BRAIN Biotech AG's (ETR:BNN) Revenues Pushing Shares 28% Lower
TKA
€9.32
thyssenkrupp
7D
1.6%
1Y
137.6%

TKA: Revenue Resilience And Workforce Cuts Will Support Share Re-Rating

Analysts have raised their fair value estimate for thyssenkrupp from EUR 13.00 to EUR 14.00, reflecting a higher Street price target of EUR 7.70 versus EUR 6.30 previously as they factor in stronger top line growth despite lower margin expectations. Analyst Commentary Bullish analysts highlight that the recent increase in the Street price target signals growing confidence in thyssenkrupp's ability to execute on its strategic initiatives, even in a more challenging margin environment.
WCH
€68.40
Wacker Chemie
7D
1.5%
1Y
-2.3%

WCH: Restructuring Uncertainty And Trade Policy Risks Will Likely Pressure Shares

Analysts have modestly reduced their price targets for Wacker Chemie, trimming expectations by a few euros per share as they factor in slower revenue growth, thinner profit margins, and valuation headwinds while awaiting clarity on U.S. trade policy and the company restructuring. Analyst Commentary Bearish analysts have shifted to a more cautious stance on Wacker Chemie, emphasizing execution risks around the ongoing restructuring, uncertainty over U.S. trade policy decisions, and a less supportive earnings backdrop.
2HRA
€4.29
H&R GmbH KGaA
7D
-2.7%
1Y
26.5%
NDA
€124.20
Aurubis
7D
2.3%
1Y
61.9%

NDA Risks Around Major Investment Projects Will Likely Cap Share Price Upside

Narrative Update on Aurubis The analyst price target for Aurubis has been raised from EUR 60 to EUR 78. This reflects analysts' expectations for stronger revenue growth, improved profit margins, and a more attractive future valuation multiple.
ACT
€155.00
AlzChem Group
7D
6.7%
1Y
171.9%

ACT: New Creatine Capacity And Partnerships Will Support Balanced Long Term Outlook

Analysts have raised their price target for AlzChem Group from €97.00 to €150.00, citing slightly stronger expectations for long term revenue growth and a higher justified future P E multiple, despite a modestly lower profit margin outlook. What's in the News AlzChem Group has approved an approximately EUR 120 million investment program to build a more automated creatine production plant and related infrastructure, targeting additional annual sales in the early triple-digit million euro range.
NTG
€11.90
Nabaltec
7D
-2.5%
1Y
-11.9%
EIS
€18.50
Eisen- und Hüttenwerke
7D
-1.6%
1Y
58.1%
UZU
€70.00
Uzin Utz
7D
-2.1%
1Y
44.0%
9MQ
€14.00
HWK 1365
7D
-8.5%
1Y
-65.2%